Company Search:
Advanced Search
Sponsored Links
Abliva AB Company Snapshot
Abliva AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abliva AB with three other miscellaneous service companies in Europe: Deutsche Biotech Innovativ AG of GERMANY (2019 sales of 10,596.34 Euros [US$12,540.03 ] ), Xintela AB (38,000.00 Swedish Kronor [US$4,402.68 ] ), and Predilife SA which is based in FRANCE (22,872.00 Euros [US$27,067.41 ] ).

Sales Analysis. Sales increased substantially in 2019: Abliva AB reported sales of SEK 134,000.00 (US$15.53 thousand) for the year ending December of 2019. This represents an increase of 2,580.0% versus 2018, when the company's sales were SEK 5,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Abliva AB
  Stock Performance Chart for Abliva AB
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): .88
(Figures in Swedish Kronor)
1 Week 8.4%   13 Weeks -3.4%  
4 Weeks -12.1%   52 Weeks -29.1%  
Abliva AB Key Data:
  Ticker: ABLI Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 134,000
(Year Ending Jan 2020).
Employees: 12
  Currency: Swedish Kronor Market Cap: 245,178,491
  Fiscal Yr Ends: December Shares Outstanding: 278,928,886
  Share Type: Aktie Closely Held Shares: 81,705,114
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.